Metabolomic analysis of human disease and its application to the eye

Journal of Ocular Biology, Diseases, and Informatics

Volumn 2, Issue 4, 2009, Pages 235-242

  Young, Stephen P ^a   Wallace, Graham R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Diagnosis; Disease; Inflammation; Metabolism; Metabolite; Metabolomics; NMR; Ocular disease; Uveitis

Indexed keywords

AMINO ACID COMPOSITION; CEREBROSPINAL FLUID; EYE DISEASE; HUMAN; INFLAMMATION; LENS; METABOLOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UVEITIS;

EID: 76849093338     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-009-9038-2     Document Type: Review

References (77)

1. Nordstrom A, Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol. 2009 doi:10.1007/s11481-009-9156-4.
2. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-78.
3. Van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 2009; 60: 916-23.
4. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritisspecific autoantibodies. J Clin Invest. 1998; 101: 273-81.
5. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis-Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996; 39: 732-5.
6. Evans JR, Fletcher AE, Wormald RP. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol. 2005; 89: 550-3.
7. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP, et al. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med. 2003; 35: 1582-8.
8. Pattison DJ, Silman AJ, Goodson NJ, Lunt M, Bunn D, Luben R, et al. Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study. Ann Rheum Dis. 2004; 63: 843-7.
9. KimSK, Park SH, Shin IH, Choe JY. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol. 2008; 35: 995-1001.
10. Kallberg H, Padyukov L, Ronnelid J, Klareskog L, Alfredsson L. Ethanol consumption is associated with decreased risks for developing RA results from the Swedish EIRA study. Ann Rheum Dis. 2007; 66: 92-93
11. Shah SH, Hauser ER, Bain JR, Muehlbauer MJ, Haynes C, Stevens RD, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol. 2009; 5: 258.
12. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A. 1971; 68: 2374-6.
13. Young SP, Nessim M, Falciani F, TrevinoV, Banerjee SP, Scott RAH, et al. Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease. Mol Vis. 2009; 15: 1210-7.
14. Tiziani S, Emwas AH, Lodi A, Ludwig C, Bunce CM, Viant MR, et al. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal Biochem. 2008; 377: 16-23.
15. Weckwerth W, Morgenthal K. Metabolomics: from pattern recognition to biological interpretation. Drug Discov Today. 2005; 10: 1551-8.
16. Viant MR. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Commun. 2003; 310: 943-8.
17. Griffin JL. Metabolic profiles to define the genome: can we hear the phenotypes? Philos Trans R Soc Lond B Biol Sci. 2004; 359: 857-1.
18. Miller MG. Environmental metabolomics: a SWOT analysis (strengths, weaknesses, opportunities, and threats). J Proteome Res. 2007; 6: 540-545
19. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: The Human Metabolome Database. Nucleic Acids Res. 2007; 35: D521-6.
20. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009; 37: W652-60.
21. Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol. 2005; 3: 557-5.
22. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr. 2005; 82: 497-503.
23. Hotelling H. Analysis of a complex of statistical variables into principal components. J Educ Psychol. 1933; 24: 417-1.
24. Hotelling H. Analysis of a complex of statistical variables into principal components. J Educ Psychol. 1933; 24: 498-520.
25. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007; 6: 469-79.
26. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002; 8: 1439-44.
27. Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, Schofield PM, et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med. 2006; 12: 705-10.
28. Sinclair AB, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - A diagnostic tool? NMR Biomed. 2009 doi: 10.1002/nbm.1428.
29. Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applications in biomedical magnetic resonance. Prog Nucl Magn Reson Spectrosc. 2001; 39: 1-40.
30. Bijlsma S, Bobeldijk L, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem. 2006; 78: 567-74.
31. Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF. A 1H NMRbasedmetabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 2003; 33: 1103-15.
32. Smith LM, Maher AD,Want EJ, Elliott P, Stamler J, Hawkes GE, et al. Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. Anal Chem. 2009; 81: 4847-56.
33. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008; 453: 396-401.
34. Gu H, Pan Z, Xi B, Hainline BE, Shanaiah N, Asiago V, et al. (1) H NMR metabolomics study of age profiling in children. NMR Biomed. 2009; 22: 826-33.
35. Bertram HC, Duus JO, Petersen BO, Hoppe C, Larnkjaer A, Schack-Nielsen L, et al. Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to retrospective infant plasma parameters. Metabolism. 2009; 58: 1039-45.
36. Gupta RK, Bhatia V, Poptani H, Gujral RB. Brain metabolite changes on in-vivo proton magnetic-resonance spectroscopy in children with congenital hypothyroidism. J Pediatr. 1995; 126: 389-92.
37. Gupta P, Gokhale R, Kirschner BS. 6-Mercaptopurine metabolite levels in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 33: 450-4.
38. Chung YL, Rider LG, Bell JD, Summers RM, Zemel LS, Rennebohm RM, et al. Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis & Rheumatism - Arthritis Care & Research. 2005; 53: 565-70.
39. Nuttall SL, Martin U, Sinclair AJ, Kendall MJ. Glutathione: in sickness and in health. Lancet. 1998; 351: 645-6.
40. Li J, Quan N, Bray TM. Supplementation of N-acetylcysteine normalizes lipopolysaccharide-induced nuclear factor kappaB activation and proinflammatory cytokine production during early rehabilitation of protein malnourished mice. J Nutr. 2002; 132: 3286-92.
41. Mayr M, Chung YL, Mayr U, Yin XK, Ly L, Troy H, et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol. 2005; 25: 2135-42.
42. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NHP, Verheij ER, et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biology. 2007; 8: R200.
43. Saude EJ, Obiefuna IP, Somorjai RL, Ajamian F, Skappak C, Ahmad T, et al. Metabolomic biomarkers in a model of asthma exacerbation urine nuclear magnetic resonance. Am J Resp Crit Care Med. 2009; 179: 25-34.
44. Wolak JE, Esther CR, O'Connell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers. 2009; 14: 55-60.
45. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007; 6: 546-51.
46. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE. 2009; 4: e6386.
47. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009; 106: 3698-703.
48. Yi LZ, Yuan DL, Che ZH, Liang YZ, Zhou ZG, Gao HY, et al. Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases. Metabolomics. 2008; 4: 30-8.
49. Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci USA. 2005; 102: 9901-6.
50. Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, Parikka V, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008; 205: 2975-84.
51. Huo T, Cai S, Lu X, Sha Y, Yu M, Li F. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal. 2009; 49: 976-82.
52. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature. 2006; 440: 1073-77.
53. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457: 910-4.
54. Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, et al. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta. 2009; 648: 98-104.
55. Gao H, Lu Q, Liu X, Cong H, Zhao L, Wang H, et al. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Can Sci. 2009; 100: 782-5.
56. Serkova NJ, Glunde K. Metabolomics of cancer. Methods Mol Biol. 2009; 520: 273-95.
57. Bental M, Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med. 1993; 29: 317-26.
58. Nakamura H, Makino Y, Okamoto K, Poellinger L, Ohnuma K, Morimoto C, et al. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J Immunol. 2005; 174: 7592-9.
59. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002; 16: 769-77.
60. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class-i- restricted lymphocytes-T. Nature. 1989; 337: 651-3.
61. Cham CM, Gajewski TF. Glucose availability regulates IFNgamma production and p70S6 kinase activation in CD8+ effector T cells. J Immunol. 2005; 174: 4670-7.
62. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109: 3812-9.
63. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 2001; 70: 478-90.
64. Beckert S, Farrahi F, Aslam RS, Scheuenstuhl H, Konigsrainer A, Hussain MZ, et al. Lactate stimulates endothelial cell migration. Wound Repair Regen. 2006; 14: 321-4.
65. Breen EC. VEGF in biological control. J Cell Biochem. 2007; 102: 1358-67.
66. Greiner JV, Kopp SJ, Glonek T. Phosphorus nuclear magnetic resonance and ocular metabolism. Surv Ophthalmol. 1985; 30: 189-202.
67. Greiner JV, Chanes LA, Glonek T. Comparison of phosphate metabolites of the ocular humors. Ophthalmic Res. 1991; 23: 92-7.
68. Midelfart A, Dybdahl A, Gribbestad S. Detection of different metabolites in the rabbit lens by high resolution 1H NMR spectroscopy. Curr Eye Res. 1996; 15: 1175-81. (Pubitemid 27052884)
69. Midelfart A, Dybdahl A, Gribbestad IS. Metabolic analysis of the rabbit cornea by proton nuclear magnetic resonance spectroscopy. Ophthalmic Res. 1996; 28: 319-29. (Pubitemid 26418286)
70. Satake M, Dmochowska B, Nishikawa Y, Madaj J, Xue J, Guo Z, et al. Vitamin C metabolomic mapping in the lens with 6-deoxy-6-fluoro-ascorbic acid and high-resolution 19F-NMR spectroscopy. Invest Ophthalmol Vis Sci. 2003; 44: 2047-58.
71. Risa O, Saether O, Lofgren S, Soderberg PG, Krane J, Midelfart A. Metabolic changes in rat lens after in vivo exposure to ultraviolet irradiation: measurements by high resolution MAS 1H NMR spectroscopy. Invest Ophthalmol Vis Sci. 2004; 45: 1916-21.
72. Saether O, Krane J, Risa O, Cejkova J, Midelfart A. Highresolution MAS H-1 NMR spectroscopic analysis of rabbit cornea after treatment with dexamethasone and exposure to UV-B radiation. Curr Eye Res. 2005; 30: 1041-9.
73. Tessem MB, Bathen TF, Cejkova J, Midelfart A. Effect of UV-A and UV-B irradiation on the metabolic profile of aqueous Humor in rabbits analyzed by H-1 NMR spectroscopy. Invest Opthalmol Vis Sci. 2005; 46: 776-81.
74. Tessem MB, Bathen TF, Lofgren S, Saether O, Mody V, Meyer L, et al. Biological response in various compartments of the rat lens after in vivo exposure to UVR-B analyzed by HR-MAS H-1 NMR spectroscopy. Invest Opthalmol Vis Sci. 2006; 47: 5404-11.
75. Fris M, Cejkova J, Midelfart A. The effect of single and repeated UVB radiation on rabbit lens. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 551-8.
76. Midelfart A. Metabonomics - A new approach in ophthalmology. Acta Ophthalmol. 2009; 87: 697-703.
77. Coen M, Holmes E, Lindon JC, Nicholson JK. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 2008; 21: 9-27.